View in EDS HTML Full Text PDF Full Text

Roflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body: The ARRECTOR Phase 3 Randomized Clinical Trial.

Saved in:
Bibliographic Details
Title: Roflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body: The ARRECTOR Phase 3 Randomized Clinical Trial.
Authors: Gooderham MJ; SKiN Centre for Dermatology, Peterborough, Ontario, Canada.; Probity Medical Research, Peterborough, Ontario, Canada.; Department of Medicine, Queen's University, Peterborough, Ontario, Canada., Alonso-Llamazares J; Driven Research, Coral Gables, Florida., Bagel J; Psoriasis Treatment Center of Central New Jersey, East Windsor, New Jersey., Bhatia N; Therapeutics Clinical Research, San Diego, California., Bukhalo M; Arlington Dermatology, Rolling Meadows, Illinois., DuBois J; DermResearch, Austin, Texas., Ferris LK; Department of Dermatology, University of Pittsburgh, Pittsburgh, Pennsylvania., Green L; George Washington University School of Medicine, Rockville, Maryland., Kircik LH; Waldman Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.; Department of Dermatology, Indiana Medical Center, Indianapolis.; Physicians Skin Care, Louisville, Kentucky.; Skin Sciences, Louisville, Kentucky., Lockshin B; DermAssociates, Rockville, Maryland., Loo WJ; DermEffects, London, Ontario, Canada.; Western University, London, Ontario, Canada.; Probity Medical Research, London, Ontario, Canada., Papp KA; Probity Medical Research, Waterloo, Ontario, Canada.; Division of Dermatology, Temerty Faculty of Medicine, University of Toronto, Ontario, Canada.; Alliance Clinical Trials, Waterloo, Ontario, Canada., Soung J; Southern California Dermatology, Santa Ana., Seal MS; Arcutis Biotherapeutics, Westlake Village, California., Snyder S; Arcutis Biotherapeutics, Westlake Village, California., Kato S; Arcutis Biotherapeutics, Westlake Village, California., Krupa D; Arcutis Biotherapeutics, Westlake Village, California., Burnett P; Arcutis Biotherapeutics, Westlake Village, California., Berk DR; Arcutis Biotherapeutics, Westlake Village, California., Chu DH; Arcutis Biotherapeutics, Westlake Village, California.
Source: JAMA dermatology [JAMA Dermatol] 2025 Jul 01; Vol. 161 (7), pp. 698-706.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40332898
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Roflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body: The ARRECTOR Phase 3 Randomized Clinical Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gooderham+MJ%22">Gooderham MJ</searchLink>; SKiN Centre for Dermatology, Peterborough, Ontario, Canada.; Probity Medical Research, Peterborough, Ontario, Canada.; Department of Medicine, Queen's University, Peterborough, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Alonso-Llamazares+J%22">Alonso-Llamazares J</searchLink>; Driven Research, Coral Gables, Florida.<br /><searchLink fieldCode="AU" term="%22Bagel+J%22">Bagel J</searchLink>; Psoriasis Treatment Center of Central New Jersey, East Windsor, New Jersey.<br /><searchLink fieldCode="AU" term="%22Bhatia+N%22">Bhatia N</searchLink>; Therapeutics Clinical Research, San Diego, California.<br /><searchLink fieldCode="AU" term="%22Bukhalo+M%22">Bukhalo M</searchLink>; Arlington Dermatology, Rolling Meadows, Illinois.<br /><searchLink fieldCode="AU" term="%22DuBois+J%22">DuBois J</searchLink>; DermResearch, Austin, Texas.<br /><searchLink fieldCode="AU" term="%22Ferris+LK%22">Ferris LK</searchLink>; Department of Dermatology, University of Pittsburgh, Pittsburgh, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Green+L%22">Green L</searchLink>; George Washington University School of Medicine, Rockville, Maryland.<br /><searchLink fieldCode="AU" term="%22Kircik+LH%22">Kircik LH</searchLink>; Waldman Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.; Department of Dermatology, Indiana Medical Center, Indianapolis.; Physicians Skin Care, Louisville, Kentucky.; Skin Sciences, Louisville, Kentucky.<br /><searchLink fieldCode="AU" term="%22Lockshin+B%22">Lockshin B</searchLink>; DermAssociates, Rockville, Maryland.<br /><searchLink fieldCode="AU" term="%22Loo+WJ%22">Loo WJ</searchLink>; DermEffects, London, Ontario, Canada.; Western University, London, Ontario, Canada.; Probity Medical Research, London, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Papp+KA%22">Papp KA</searchLink>; Probity Medical Research, Waterloo, Ontario, Canada.; Division of Dermatology, Temerty Faculty of Medicine, University of Toronto, Ontario, Canada.; Alliance Clinical Trials, Waterloo, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Soung+J%22">Soung J</searchLink>; Southern California Dermatology, Santa Ana.<br /><searchLink fieldCode="AU" term="%22Seal+MS%22">Seal MS</searchLink>; Arcutis Biotherapeutics, Westlake Village, California.<br /><searchLink fieldCode="AU" term="%22Snyder+S%22">Snyder S</searchLink>; Arcutis Biotherapeutics, Westlake Village, California.<br /><searchLink fieldCode="AU" term="%22Kato+S%22">Kato S</searchLink>; Arcutis Biotherapeutics, Westlake Village, California.<br /><searchLink fieldCode="AU" term="%22Krupa+D%22">Krupa D</searchLink>; Arcutis Biotherapeutics, Westlake Village, California.<br /><searchLink fieldCode="AU" term="%22Burnett+P%22">Burnett P</searchLink>; Arcutis Biotherapeutics, Westlake Village, California.<br /><searchLink fieldCode="AU" term="%22Berk+DR%22">Berk DR</searchLink>; Arcutis Biotherapeutics, Westlake Village, California.<br /><searchLink fieldCode="AU" term="%22Chu+DH%22">Chu DH</searchLink>; Arcutis Biotherapeutics, Westlake Village, California.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101589530%22">JAMA dermatology</searchLink> [JAMA Dermatol] 2025 Jul 01; Vol. 161 (7), pp. 698-706.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101589530 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2168-6084 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221686068%22">21686068 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Dermatol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40332898
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1001/jamadermatol.2025.1136
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 698
    Titles:
      – TitleFull: Roflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body: The ARRECTOR Phase 3 Randomized Clinical Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gooderham MJ
      – PersonEntity:
          Name:
            NameFull: Alonso-Llamazares J
      – PersonEntity:
          Name:
            NameFull: Bagel J
      – PersonEntity:
          Name:
            NameFull: Bhatia N
      – PersonEntity:
          Name:
            NameFull: Bukhalo M
      – PersonEntity:
          Name:
            NameFull: DuBois J
      – PersonEntity:
          Name:
            NameFull: Ferris LK
      – PersonEntity:
          Name:
            NameFull: Green L
      – PersonEntity:
          Name:
            NameFull: Kircik LH
      – PersonEntity:
          Name:
            NameFull: Lockshin B
      – PersonEntity:
          Name:
            NameFull: Loo WJ
      – PersonEntity:
          Name:
            NameFull: Papp KA
      – PersonEntity:
          Name:
            NameFull: Soung J
      – PersonEntity:
          Name:
            NameFull: Seal MS
      – PersonEntity:
          Name:
            NameFull: Snyder S
      – PersonEntity:
          Name:
            NameFull: Kato S
      – PersonEntity:
          Name:
            NameFull: Krupa D
      – PersonEntity:
          Name:
            NameFull: Burnett P
      – PersonEntity:
          Name:
            NameFull: Berk DR
      – PersonEntity:
          Name:
            NameFull: Chu DH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2025 Jul 01
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2168-6084
          Numbering:
            – Type: volume
              Value: 161
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: JAMA dermatology
              Type: main
ResultId 1